Ustekinumab in Hidradenitis Suppurativa: A Systematic Review and Meta-analysis

• Auteurs principaux: Rahul Masson (Auteur), Justine Seivright (Auteur), Tristan Grogan (Auteur), Swetha Atluri (Auteur), Iltefat Hamzavi (Auteur), Marcia Hogeling (Auteur), Vivian Y. Shi (Auteur), Jennifer L. Hsiao (Auteur)
• Format: Livre
• Publié: Adis, Springer Healthcare, 2024-06-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Abstract Introduction Hidradenitis suppurativa (HS) is a frequently debilitating, inflammatory skin condition. Patients may have a limited response to adalimumab, currently the only Food and Drug Administration (FDA)-approved biologic treatment for HS. Ustekinumab is an interleukin-12/23 inhibitor t...